世界のメニエール病治療薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP07185)
◆英語タイトル:Global Meniere's Disease Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP07185
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、メニエール病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。メニエール病治療薬の種類別市場規模(乗り物酔い止め薬、吐き気止め薬、その他)、用途別市場規模(病院、クリニック、医学研究センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Roche、WellSpring Pharmaceutical、Auris Medical、Novartis、Sound Pharmaceuticals、Pfizer、Otonomy、Jubilant Cadista
・地域別グローバル市場分析 2015年-2020年
・メニエール病治療薬の北米市場(アメリカ、カナダ、メキシコ)
・メニエール病治療薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・メニエール病治療薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・メニエール病治療薬の南米市場(ブラジル、アルゼンチン)
・メニエール病治療薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:乗り物酔い止め薬、吐き気止め薬、その他
・用途別分析:病院、クリニック、医学研究センター、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Meniere’s Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Meniere’s Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Meniere’s Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Meniere’s Disease Drugs market has been segmented into:
Motion Sickness Medication
Anti-Nausea Medication
Others

By Application, Meniere’s Disease Drugs has been segmented into:
Hospitals
Clinics
Medical Research Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Meniere’s Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Meniere’s Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meniere’s Disease Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Meniere’s Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Meniere’s Disease Drugs Market Share Analysis
Meniere’s Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Meniere’s Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meniere’s Disease Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Meniere’s Disease Drugs are:
Roche
WellSpring Pharmaceutical
Auris Medical
Novartis
Sound Pharmaceuticals
Pfizer
Otonomy
Jubilant Cadista

【レポートの目次】

Table of Contents

1 Meniere’s Disease Drugs Market Overview
1.1 Product Overview and Scope of Meniere’s Disease Drugs
1.2 Classification of Meniere’s Disease Drugs by Type
1.2.1 Global Meniere’s Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Meniere’s Disease Drugs Revenue Market Share by Type in 2019
1.2.3 Motion Sickness Medication
1.2.4 Anti-Nausea Medication
1.2.5 Others
1.3 Global Meniere’s Disease Drugs Market by Application
1.3.1 Overview: Global Meniere’s Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Medical Research Centers
1.3.5 Others
1.4 Global Meniere’s Disease Drugs Market by Regions
1.4.1 Global Meniere’s Disease Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Meniere’s Disease Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Meniere’s Disease Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Meniere’s Disease Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meniere’s Disease Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Meniere’s Disease Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meniere’s Disease Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 WellSpring Pharmaceutical
2.2.1 WellSpring Pharmaceutical Details
2.2.2 WellSpring Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 WellSpring Pharmaceutical SWOT Analysis
2.2.4 WellSpring Pharmaceutical Product and Services
2.2.5 WellSpring Pharmaceutical Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Auris Medical
2.3.1 Auris Medical Details
2.3.2 Auris Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Auris Medical SWOT Analysis
2.3.4 Auris Medical Product and Services
2.3.5 Auris Medical Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sound Pharmaceuticals
2.5.1 Sound Pharmaceuticals Details
2.5.2 Sound Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sound Pharmaceuticals SWOT Analysis
2.5.4 Sound Pharmaceuticals Product and Services
2.5.5 Sound Pharmaceuticals Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Otonomy
2.7.1 Otonomy Details
2.7.2 Otonomy Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Otonomy SWOT Analysis
2.7.4 Otonomy Product and Services
2.7.5 Otonomy Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Jubilant Cadista
2.8.1 Jubilant Cadista Details
2.8.2 Jubilant Cadista Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Jubilant Cadista SWOT Analysis
2.8.4 Jubilant Cadista Product and Services
2.8.5 Jubilant Cadista Meniere’s Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Meniere’s Disease Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Meniere’s Disease Drugs Players Market Share
3.2.2 Top 10 Meniere’s Disease Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Meniere’s Disease Drugs Revenue and Market Share by Regions
4.2 North America Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
5 North America Meniere’s Disease Drugs Revenue by Countries
5.1 North America Meniere’s Disease Drugs Revenue by Countries (2015-2020)
5.2 USA Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
6 Europe Meniere’s Disease Drugs Revenue by Countries
6.1 Europe Meniere’s Disease Drugs Revenue by Countries (2015-2020)
6.2 Germany Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
6.4 France Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Meniere’s Disease Drugs Revenue by Countries
7.1 Asia-Pacific Meniere’s Disease Drugs Revenue by Countries (2015-2020)
7.2 China Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
7.5 India Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
8 South America Meniere’s Disease Drugs Revenue by Countries
8.1 South America Meniere’s Disease Drugs Revenue by Countries (2015-2020)
8.2 Brazil Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Meniere’s Disease Drugs by Countries
9.1 Middle East & Africa Meniere’s Disease Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Meniere’s Disease Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Meniere’s Disease Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Meniere’s Disease Drugs Market Forecast by Type (2019-2024)
10.3 Motion Sickness Medication Revenue Growth Rate (2015-2025)
10.4 Anti-Nausea Medication Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Meniere’s Disease Drugs Market Segment by Application
11.1 Global Meniere’s Disease Drugs Revenue Market Share by Application (2015-2020)
11.2 Meniere’s Disease Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Medical Research Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Meniere’s Disease Drugs Market Size Forecast (2021-2025)
12.1 Global Meniere’s Disease Drugs Market Size Forecast (2021-2025)
12.2 Global Meniere’s Disease Drugs Market Forecast by Regions (2021-2025)
12.3 North America Meniere’s Disease Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Meniere’s Disease Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Meniere’s Disease Drugs Revenue Market Forecast (2021-2025)
12.6 South America Meniere’s Disease Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Meniere’s Disease Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Roche、WellSpring Pharmaceutical、Auris Medical、Novartis、Sound Pharmaceuticals、Pfizer、Otonomy、Jubilant Cadista

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のメニエール病治療薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Meniere's Disease Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。